References:
1)     Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H, Lin X, Wei S, Wu T. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020; 323:1-9.
2)     Kotecha RS. Challenges posed by COVID-19 to children with cancer. Lancet Oncol. 2020 May;21(5):e235.
3)     Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan MS, Kearns P, Hawkins DS, Challinor J, Morrissey L, Fuchs J, Marcus K, Balduzzi A, Basset-Salom L, Caniza M, Baker JN, Kebudi R, Hessissen L, Sullivan R, Pritchard-Jones K. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020 May 13:e28409.
4)     de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata C, Peretó A, Madero L COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020 May 8:e28397.
5)    Terenziani M, Massimino M, Biassoni V, Casanova M, Chiaravalli S, Ferrari A, Luksch R, Meazza C, Podda M, Schiavello E, Spreafico F.SARS-CoV-2 disease and children under treatment for cancer.Pediatr Blood Cancer. 2020 May 6:e28346.
6)     Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL.  COVID19 in Children With Cancer in New York City. JAMA Oncol. 2020 May 13:e202028.
7)     André N, Rouger-Gaudichon J, Brethon B, Phulpin A, Thébault É, Pertuisel S, Gandemer V. COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms? Pediatr Blood Cancer. 2020 May 8:e28392
Acknowledgement : None
Conflict of interest : None